Literature DB >> 17127019

Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease.

M M Harmsen1, C B van Solt, H P D Fijten, L van Keulen, R A Rosalia, K Weerdmeester, A H M Cornelissen, M G M De Bruin, P L Eblé, A Dekker.   

Abstract

Foot-and-mouth disease (FMD) is a highly contagious disease that occasionally causes outbreaks in Europe. There is a need for therapies that provide rapid protection against FMD in outbreak situations. We aim to provide such rapid protection by passive immunization with llama single-domain antibody fragments (VHHs). Twenty-four VHHs binding serotype O FMDV in vitro were isolated from immunized llamas by phage display and expressed in bakers yeast for further characterization. They recognized four functionally independent antigenic sites. Six strongly FMDV neutralizing VHHs bound to a peptide representing the GH-loop of viral protein 1 known to be involved in binding to the cellular receptor of FMDV. Clone M8, recognizing this antigenic site, and clone M23, recognizing another antigenic site, showed synergistic in vitro virus neutralization. Three FMDV specific VHHs were PEGylated in order to decrease their rapid blood clearance and thus enable in vivo guinea pig protection experiments. Passive immunization with individual VHHs showed no protection, but a mixture of M8 and M23 showed partial transient protection. The protection afforded by these VHHs was however low as compared to the complete protection afforded by convalescent guinea pig serum. In contrast, these VHHs showed far more efficient in vitro FMDV neutralization than convalescent guinea pig serum. This lack of correlation between in vitro neutralization and in vivo protection lends further credence to the notion that opsonophagocytosis of FMDV is important for protection in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17127019     DOI: 10.1016/j.vetmic.2006.10.029

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  23 in total

1.  CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells.

Authors:  Sven Jähnichen; Christophe Blanchetot; David Maussang; Maria Gonzalez-Pajuelo; Ken Y Chow; Leontien Bosch; Sindi De Vrieze; Benedikte Serruys; Hans Ulrichts; Wesly Vandevelde; Michael Saunders; Hans J De Haard; Dominique Schols; Rob Leurs; Peter Vanlandschoot; Theo Verrips; Martine J Smit
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

2.  A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.

Authors:  Zhiyong Yang; Diane Schmidt; Weilong Liu; Shan Li; Lianfa Shi; Jinliang Sheng; Kevin Chen; Hua Yu; Jacqueline M Tremblay; Xinhua Chen; Kurt H Piepenbrink; Eric J Sundberg; Ciaran P Kelly; Guang Bai; Charles B Shoemaker; Hanping Feng
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

3.  The molecular mechanism of Shiga toxin Stx2e neutralization by a single-domain antibody targeting the cell receptor-binding domain.

Authors:  Alvin W H Lo; Kristof Moonens; Maia De Kerpel; Lea Brys; Els Pardon; Han Remaut; Henri De Greve
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

4.  Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domain.

Authors:  Martin A Rossotti; Andrés González-Techera; Julio Guarnaschelli; Lucia Yim; Ximena Camacho; Marcelo Fernández; Pablo Cabral; Carmen Leizagoyen; José A Chabalgoity; Gualberto González-Sapienza
Journal:  MAbs       Date:  2015       Impact factor: 5.857

5.  Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1.

Authors:  Willie W L Koh; Soren Steffensen; Maria Gonzalez-Pajuelo; Bart Hoorelbeke; Andrea Gorlani; Agnieszka Szynol; Anna Forsman; Marlén M I Aasa-Chapman; Hans de Haard; Theo Verrips; Robin A Weiss
Journal:  J Biol Chem       Date:  2010-04-16       Impact factor: 5.157

6.  Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice.

Authors:  Lorena Garaicoechea; Aurelien Olichon; Gisela Marcoppido; Andrés Wigdorovitz; Marina Mozgovoj; Linda Saif; Thomas Surrey; Viviana Parreño
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

7.  Characterization of epitope-tagged foot-and-mouth disease virus.

Authors:  Julian Seago; Terry Jackson; Claudia Doel; Elizabeth Fry; David Stuart; Michiel M Harmsen; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2012-07-18       Impact factor: 3.891

8.  Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation.

Authors:  M M Harmsen; C B van Solt; H P D Fijten
Journal:  Appl Microbiol Biotechnol       Date:  2009-05-12       Impact factor: 4.813

Review 9.  Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

Authors:  Janusz Wesolowski; Vanina Alzogaray; Jan Reyelt; Mandy Unger; Karla Juarez; Mariela Urrutia; Ana Cauerhff; Welbeck Danquah; Björn Rissiek; Felix Scheuplein; Nicole Schwarz; Sahil Adriouch; Olivier Boyer; Michel Seman; Alexei Licea; David V Serreze; Fernando A Goldbaum; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Med Microbiol Immunol       Date:  2009-06-16       Impact factor: 3.402

10.  Novel Capsid-Specific Single-Domain Antibodies with Broad Foot-and-Mouth Disease Strain Recognition Reveal Differences in Antigenicity of Virions, Empty Capsids, and Virus-Like Particles.

Authors:  Haozhou Li; Aldo Dekker; Shiqi Sun; Alison Burman; Jeroen Kortekaas; Michiel M Harmsen
Journal:  Vaccines (Basel)       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.